Camussi G, Tetta C, Bussolino F, Andres G, Turello E, Baglioni C
Cattedra di Nefrologia Sperimentale, I Facoltà di Medicina e Chirurgia, Università di Napoli, Italy.
J Lipid Mediat. 1990;2 Suppl:S203-13.
Platelet-activating factor (PAF) is a phospholipid that exhibits a wide range of biological activities as a secondary mediator of inflammation and anaphylaxis. Primary mediators of inflammation, such as interleukin-1 and tumor necrosis factor, stimulate PAF release by monocytes/macrophages, neutrophils and endothelial cells. PAF has also been implicated in cell-mediated hypersensitivity reactions. This review will focus on recent data suggesting that the local production of these mediators in glomeruli by infiltrating inflammatory cells or resident cells may influence the clinicopathological expression of glomerular disease. Results from in vitro and experimental studies suggest that these mediators alter the growth pattern of glomerular cells and the composition of secreted matrix, leading to scar formation and eventually to glomerulosclerosis.
血小板活化因子(PAF)是一种磷脂,作为炎症和过敏反应的二级介质,具有广泛的生物学活性。炎症的主要介质,如白细胞介素-1和肿瘤坏死因子,刺激单核细胞/巨噬细胞、中性粒细胞和内皮细胞释放PAF。PAF也与细胞介导的超敏反应有关。本综述将聚焦于近期数据,这些数据表明,炎症细胞或驻留细胞在肾小球中局部产生这些介质可能会影响肾小球疾病的临床病理表现。体外和实验研究结果表明,这些介质会改变肾小球细胞的生长模式和分泌基质的组成,导致瘢痕形成并最终发展为肾小球硬化。